Kymera receives FDA fast track for asthma drug KT-621

April 13, 2026 7:01 AM

Kymera Therapeutics Inc. (NASDAQ: KYMR) announced that the U.S. Food and Drug Administration has granted Fast Track designation to KT-621 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found